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ABSTRACT 
The injection of drug of abuse into muscle tissue leads to myositis, pain and ultimately fibrosis, atrophy and may be 
contracture of the specific muscle/s. Cases reporting the muscular side effects of intra venous (IV) drug abuse are few and this 
particular complication of drug abuse is not very well documented. We report a patient with myositis leading to atrophy of the 
shoulder muscles and following this the patient developed limitation of movements. 
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arenteral drug abuse has wide spread ramifications 
like indurations of skin, ulcerations, skin popping, 
thrombophlebitis, and the other systemic 
complications [1]. Drug abuse is a major public health 
problem among younger population [2]. The injection of 
drug of abuse into muscle tissue leads to myositis, pain 
and ultimately fibrosis, atrophy and may be contracture of 
the specific muscle/s [3,4]. Deltoid contracture causes a 
fixed abducted posture, rightly called as ‘arm levitation 
sign’, indicating chronic injection myopathy [5]. Cases 
reporting the muscular side effects of IV drug abuse are 
few and this particular complication of drug abuse is not 
very well documented [4]. The atrophy of muscles leading 
to limitations in movement is still rare. We report a patient 
with myositis leading to atrophy of the shoulder muscles 
and following this the patient developed limitation of 
movements. 
CASE REPORT 
Mr. X, a young married educated upto primary level class 
III, employee in the government sector presented to the  
 
de-addiction outpatient services of a tertiary care hospital, 
with complaints of using injectable pentazocine for the 
past 2 years. The patient reported to having used the 
injections for headache (this was suggested by his friend), 
and he felt relief on using the injection. Initially, he would 
use it once in a week or fortnight; however within three 
months, he started using it once to twice a week. In a six 
month period, he started taking it daily. Within a year he 
started indiscriminate and two times to three times a day 
use of the drug. The patient would randomly inject the 
drug in the arm, elbow, and rarely in the legs. The patient 
took care not to share needles; however, he did not make 
efforts to find a vein for injection. 
About a year back, patient noticed that he had severe 
pain after injection in shoulder and following the injection, 
he developed restriction of movement of the shoulder 
joint. He developed swelling with tenderness at the 
shoulder joint and there was induration at the injection site. 
The induration subsequently resolved; however, the pain 
and restriction in mobility persisted. Gradually the patient 
P 
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and his family members notice that the shoulder joint was 
losing the contour of roundedness and was flattening. The 
patient continued to inject indiscriminately with 
subsequent worsening in the movement, contour and pain. 
 
 
 
The patient was taken to the orthopaedic department 
where examination revealed that he had developed deltoid 
muscle atrophy along with the frozen shoulder and the 
cause was ascertained as pentazocine abuse for which he 
was referred to the de-addiction clinic. The patient did not 
complaint of any gross muscle weakness. The limitation of 
movements was compensated by using the other muscles 
around the shoulder joint. He was a normotensive non 
diabetic individual. Family history was non contributory, 
the family support was good. 
 
Physical examination revealed a thin-built man (48 
kg) with marked contractures involving the shoulder joint 
and loss of bulk of the shoulder joint and mild limitation of 
abduction of right shoulder and marked woody indurations 
of the deltoids. Both elbows were semi-flexed with a 
restricted range of movement on either side. Muscle power 
was normal within the limited range of movements, and 
there was no sensory deficit. 
The routine biochemical tests like haemoglobin, 
complete blood count, blood sugar, kidney and liver 
function test along with the hepatitis B and HIV tests and 
routine urine examinations were within normal limit. The 
CPK levels were marginally raised. The tests are a part of 
routine screening in drug abuse patients. A routine chest 
X-ray along with the shoulder joint X-ray was done in the 
orthopaedics department. The chest X-ray was normal. We 
suggested a muscle biopsy and a muscular electro 
physiological study for which the patient was referred to 
the neurology department. 
The patient was treated for the drug addiction. 
Rehabilitation by physiotherapy and harm reduction was 
instituted. The patient did not agree for the muscle test and 
did not give consent for the muscle biopsy. For the de 
addiction he was regular in follow up and in two months 
was off addiction. He was prescribed opioid antagonist 
along with nutritional supplements. He continues to be 
addiction free after six months; however the muscle bulk 
has not improved, but there is some improvement in the 
movement of the shoulder joint. 
Fig 1 Arm levitation sign 
Fig 2 Kyphosis  
Fig 3 Flaying of scapula 
Fig 4 frozen shoulders 
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DISCUSSION 
Superficial skin complications of parenteral drug abuse 
have been described by many authors Schlicher et al.[1] 
Swanson et al [6], noted a 33% incidence of brawny 
induration of skin and underlying tissue. Case reports and 
case series [7] have discussed the issues of cutaneous 
complications with pentazocine, there are few case reports 
[4]
 
and case series [9]
 
discussing the same from India and a 
few discussing about myopathy and fibrosis [4]. The list of 
complications was later extended by Joong et al [3] who 
described a fibrous myopathy with intramuscular 
pentazocine injections. The patients described by them had 
woody induration of muscles with secondary contractures. 
Contractures of Deltoid muscle cause a fixed abducted 
posture, which is named ‘arm levitation sign’, a signal of 
chronic injection myopathy [5]. The history of progressive 
decline in mobility with generalised stiffness in the index 
patient may appear to be a joint disease [9] (my patient 
was referred by the orthopaedic specialist). However, the 
extensive induration of soft tissue with resultant 
contractures and normal radiographic studies point to the 
non orthopaedic nature of his deformity [10]. A classical 
‘arm levitation’ sign was lacking, but somewhat related 
picture was seen (Fig. 1). Frozen shoulder has also been 
mentioned to be an associated feature which was present in 
my patient [9] (Fig 4). Flaying of scapula (Fig 3), along 
with the kyphosis was also visible in our subject. On the 
contrary, case reports have mentioned the presence of 
lordosis in such individuals [4]. 
The history of chronic pentazocine injection in 
conjunction with the typical muscular involvement gives 
an indication of this condition. An EMG and biopsy would 
be highly helpful to arrive at the diagnosis; marginally 
raised creatine kinase should be viewed with suspicion. 
The mechanism of this condition is thought to be the result 
of Pentazocine which is most soluble under acidic 
conditions, and precipitation in the alkaline pH of 
extracellular tissue with secondary inflammation may be 
causative [9,10]. Repeated injections of other medications 
are not commonly reported to result in diffuse muscle 
fibrosis. Formations of crystals have been noted in the area 
of induration [9]. The role of repeated muscle trauma, 
microhaemorrhages, and infections can also be 
contributory [5]. Elevations of muscle enzymes, as seen in 
my patient is suggestive of ongoing muscle destruction, 
however the elevation was not marked. Animal studies 
utilising repeated injections of pentazocine show induction 
of localised sclerosis in guinea pigs but not in rats [3]. 
Pentazocine-induced fibrous myopathy should be kept in 
mind when a parenteral narcotic agent is required for 
management of chronic pain. 
CONCLUSION 
Pain management requires alertness on the part of 
physicians, and indiscriminate selling of dependence 
producing drugs should be banned. A good liaison among 
doctors is needed to help patients with multiple 
involvements. 
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